Nifty Pharma Today: Index Gains 0.28% in Early Trade

Quick sector takeaways

• Nifty Pharma rose 74.55 points, or 0.28%, to 26,552.65 in the early session on 7 September 2026, against a previous close of 26,478.10.
• The index was the strongest performer among the tracked NSE sector indices, while 12 of its 20 stocks advanced and eight declined.
• Gland Pharma, Natco Pharma and Divi’s Laboratories led the gains, while JB Chemicals & Pharmaceuticals was the sharpest faller.
• For the next session, investors can track whether the index sustains trade near its day high of 26,565.85 and whether positive breadth remains in place.

Early-session update, 7 September 2026: Nifty Pharma today showed measured strength at 10:00:00 AM IST, with the index holding above its previous close despite mixed moves across individual pharmaceutical shares.

Nifty Pharma today: a positive early-session start

Nifty Pharma opened at 26,472.85, slightly below the previous close, but moved into positive territory during the opening phase. At 26,552.65, the index was higher by 74.55 points from 26,478.10, a gain of 0.28%.

The advance was notable because it placed the pharma gauge at the top of the session’s sector ranking among the tracked indices. The move was not uniform across the index, but the balance of advancing stocks supported the positive reading. The index was also trading close to its intraday high, indicating that much of the early-session range had been recovered from the day’s low.

Price snapshot

The index’s opening level was 26,472.85, while the session low stood at 26,440.40. From there, Nifty Pharma moved up to a high of 26,565.85. Its last traded level of 26,552.65 was only 13.20 points below that high and 112.25 points above the low.

Against the previous close of 26,478.10, the positive change of 74.55 points reflects a 0.28% rise. The 125.45-point high-low range captures the early session’s movement. For market participants following the sector, the key observable feature was the index’s ability to trade above both its opening level and its prior close by 10:00 AM IST.

Sector ranking

Nifty Pharma was the top gaining sector index in the early session. The complete ranking of the tracked NSE sector indices, from the strongest gain to the steepest fall, was as follows:

• Nifty Pharma: up 0.28%.
• Nifty Mid Select: up 0.01%.
• Nifty Auto: down 0.05%.
• Nifty Financial Services: down 0.33%.
• Nifty Bank: down 0.40%.
• Nifty FMCG: down 0.46%.
• Nifty Metal: down 0.63%.
• Nifty IT: down 1.70%.

This comparison puts the pharma index ahead of the only other index in positive territory, Nifty Mid Select, and ahead of the six indices that were in the red. The ranking describes relative performance during this early snapshot and may change as trading progresses.

Constituent breadth

Participation within the sector was positive, with 12 Nifty Pharma stocks advancing and eight declining. There were no unchanged stocks. That produces an advance-decline ratio of 1.5, meaning gainers outnumbered decliners by three stocks.

The breadth reading adds context to the index’s 0.28% rise. Gains were distributed across several names, including Gland Pharma, Natco Pharma, Divi’s Laboratories, Granules India, Dr. Reddy’s Laboratories, Ajanta Pharma, Zydus Lifesciences, Lupin, Torrent Pharmaceuticals, Glenmark Pharmaceuticals, Laurus Labs and Aurobindo Pharma. At the same time, declines in a group of stocks kept the sector move moderate rather than broad-based in one direction.

Heavyweights versus broader participation

Among the sector’s heavyweight stocks, Divi’s Laboratories gained 0.97% to ₹9,188.50 and Torrent Pharmaceuticals rose 0.42% to ₹4,877.50. Dr. Reddy’s Laboratories added 0.56% to ₹1,157.50. These advances were offset in part by Sun Pharmaceutical Industries, down 0.09% to ₹1,897.30, and Cipla, down 0.26% to ₹1,381.40.

The session’s active-stock list also included Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla and Dr. Reddy’s Laboratories. Their mixed price moves underline that the index’s positive outcome came alongside stock-specific variation rather than identical movement across the larger names.

Key Nifty Pharma stocks

Biggest positive movers

Gland Pharma led the gainers with a 2.05% rise to ₹2,992.40, after trading between ₹2,916.90 and ₹2,998.20. Natco Pharma followed, gaining 1.36% to ₹839.90, which was also its day high. Divi’s Laboratories added 0.97% to ₹9,188.50, while Granules India rose 0.67% to ₹854.00. Dr. Reddy’s Laboratories advanced 0.56% to ₹1,157.50.

These moves provided the strongest positive stock-level readings in the sector at the early-session mark. Gland Pharma’s move was the clearest individual gain, while Natco Pharma’s price at the day high was a notable intraday observation.

Biggest negative movers

JB Chemicals & Pharmaceuticals fell 3.87% to ₹2,408.90, making it the largest decliner among Nifty Pharma stocks. The share traded as high as ₹2,525.50 and as low as ₹2,380.00 during the session. Alkem Laboratories declined 0.58% to ₹5,160.00, followed by Biocon, down 0.44% to ₹395.65.

Abbott India slipped 0.36% to ₹25,970.00 and Cipla fell 0.26% to ₹1,381.40. The presence of these declines is important context for the index’s modest, rather than outsized, gain.

Stocks to watch next session

• Gland Pharma, after its sector-leading 2.05% advance.
• Natco Pharma, which was trading at ₹839.90, its intraday high.
• Divi’s Laboratories, following a 0.97% rise to ₹9,188.50.
• JB Chemicals & Pharmaceuticals, after a 3.87% decline to ₹2,408.90.
• Sun Pharmaceutical Industries, which closed the early snapshot marginally lower at ₹1,897.30.
• Torrent Pharmaceuticals, up 0.42% at ₹4,877.50.

The constructive case

The constructive evidence is visible in three early-session readings: Nifty Pharma was the strongest sector index, it was above its previous close, and advancing stocks outnumbered declining stocks by 12 to eight. The index also stood close to its intraday high of 26,565.85 at the time of the update.

Leadership from Gland Pharma and Natco Pharma, coupled with gains in Divi’s Laboratories, Granules India and Dr. Reddy’s Laboratories, supported the broader positive tone. Positive moves in Torrent Pharmaceuticals, Glenmark Pharmaceuticals, Laurus Labs and Aurobindo Pharma added further participation.

The cautious case

The sector’s upward move was 0.28%, which signals a positive but contained early-session gain. Eight stocks were in negative territory, including Sun Pharmaceutical Industries and Cipla among the heavyweight names. JB Chemicals & Pharmaceuticals’ 3.87% decline was materially larger than the percentage gains of the leading advancers.

The index also remained below its day high by 13.20 points. As a result, the next session’s price action will help clarify whether the early strength extends or whether mixed stock-level performance continues to shape the sector’s direction.

Univest Insights

Nifty Pharma today stood out through relative strength, as it was the only tracked sector index with a gain greater than 0.01%. Its position above the previous close, along with positive breadth, gives the opening session a constructive profile.

However, the composition of the gain deserves attention. Divi’s Laboratories and Torrent Pharmaceuticals were positive among major stocks, while Sun Pharmaceutical Industries and Cipla were marginally lower. This mixed heavyweight picture means the index advance was supported by participation across several names rather than a uniform move from every large stock.

Gland Pharma’s 2.05% rise and Natco Pharma’s trade at the day high were the strongest positive observations. Conversely, the fall in JB Chemicals & Pharmaceuticals remained the dominant negative stock move and materially contrasted with the sector’s overall positive index reading.

Readers can follow the broader market context through Univest Market View alongside the pharma screen. In the next session, watch whether Nifty Pharma holds above 26,552.65 and whether the 12-to-eight advance-decline balance remains positive.

Published on 7 September 2026 at 10:00 AM IST

Frequently asked questions

What is Nifty Pharma today?

Nifty Pharma was at 26,552.65 at 10:00:00 AM IST on 7 September 2026, up 74.55 points or 0.28% from its previous close of 26,478.10.

Why was Nifty Pharma the top gaining sector index?

Nifty Pharma gained 0.28%, the highest rise among the tracked NSE sector indices. Nifty Mid Select was the next strongest, with a 0.01% gain.

What were Nifty Pharma’s intraday high and low?

The index recorded an intraday high of 26,565.85 and a low of 26,440.40 in the early session.

How was the breadth within Nifty Pharma?

Twelve Nifty Pharma stocks advanced, eight declined and none were unchanged, producing an advance-decline ratio of 1.5.

Which stocks led the gains in Nifty Pharma?

Gland Pharma rose 2.05%, Natco Pharma gained 1.36%, Divi’s Laboratories advanced 0.97%, Granules India added 0.67%, and Dr. Reddy’s Laboratories rose 0.56%.

Which stock was the biggest Nifty Pharma decliner?

JB Chemicals & Pharmaceuticals was the biggest decliner, falling 3.87% to ₹2,408.90 in the early session.